DrugDashboards

ATNAA atropine and pralidoxime chloride Auto-Injector

atropine and pralidoxime chloride · Kit · Intramuscular · Meridian Medical Technologies, LLC

NDC 11704-0777-01 · 1 KIT in 1 CARTON * .7 mL in 1 SYRINGE, GLASS * 2 mL in 1 SYRINGE, GLASS · NDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
NDA021175
TE code
Approval date
Jan 17, 2002
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of atropine and pralidoxime chloride (Kit)

LabelerStrengthFirst seenLast seen
Meridian Medical Technologies LLCJul 15, 2026Sep 2, 2026
Meridian Medical Technologies, LLCJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "ATNAA atropine and pralidoxime chloride Auto-Injector — NDC 11704-0777-01," retrieved September 3, 2026, https://drugdashboards.com/drug/11704077701.

Free to cite with attribution — see how the data is put together.